170 related articles for article (PubMed ID: 20072995)
1. [Pathogenesis of liver fibrosis: modulation of stellate cells by chemokines].
Wasmuth HE; Weiskirchen R
Z Gastroenterol; 2010 Jan; 48(1):38-45. PubMed ID: 20072995
[TBL] [Abstract][Full Text] [Related]
2. Chemokines in liver inflammation and fibrosis.
Wasmuth HE; Tacke F; Trautwein C
Semin Liver Dis; 2010 Aug; 30(3):215-25. PubMed ID: 20665374
[TBL] [Abstract][Full Text] [Related]
3. Chemokines in hepatitis C virus infection: pathogenesis, prognosis and therapeutics.
Wald O; Weiss ID; Galun E; Peled A
Cytokine; 2007 Jul; 39(1):50-62. PubMed ID: 17629707
[TBL] [Abstract][Full Text] [Related]
4. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.
Zeremski M; Petrovic LM; Talal AH
J Viral Hepat; 2007 Oct; 14(10):675-87. PubMed ID: 17875002
[TBL] [Abstract][Full Text] [Related]
5. Cirrhosis--can we reverse hepatic fibrosis?
Tangkijvanich P; Yee HF
Eur J Surg Suppl; 2002; (587):100-12. PubMed ID: 16144208
[TBL] [Abstract][Full Text] [Related]
6. Chemokines as immune mediators of liver diseases related to the metabolic syndrome.
Berres ML; Nellen A; Wasmuth HE
Dig Dis; 2010; 28(1):192-6. PubMed ID: 20460910
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease.
Apolinario A; Majano PL; Alvarez-Pérez E; Saez A; Lozano C; Vargas J; García-Monzón C
Am J Gastroenterol; 2002 Nov; 97(11):2861-70. PubMed ID: 12425561
[TBL] [Abstract][Full Text] [Related]
8. Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.
Wasmuth HE; Lammert F; Zaldivar MM; Weiskirchen R; Hellerbrand C; Scholten D; Berres ML; Zimmermann H; Streetz KL; Tacke F; Hillebrandt S; Schmitz P; Keppeler H; Berg T; Dahl E; Gassler N; Friedman SL; Trautwein C
Gastroenterology; 2009 Jul; 137(1):309-19, 319.e1-3. PubMed ID: 19344719
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.
Paik YH; Schwabe RF; Bataller R; Russo MP; Jobin C; Brenner DA
Hepatology; 2003 May; 37(5):1043-55. PubMed ID: 12717385
[TBL] [Abstract][Full Text] [Related]
10. Chemokines and their receptors in the central nervous system.
Bajetto A; Bonavia R; Barbero S; Florio T; Schettini G
Front Neuroendocrinol; 2001 Jul; 22(3):147-84. PubMed ID: 11456467
[TBL] [Abstract][Full Text] [Related]
11. Chemokine-directed immune cell infiltration in acute and chronic liver disease.
Karlmark KR; Wasmuth HE; Trautwein C; Tacke F
Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):233-42. PubMed ID: 19072358
[TBL] [Abstract][Full Text] [Related]
12. Disease-specific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis.
van der Poorten D; George J
Clin Liver Dis; 2008 Nov; 12(4):805-24, ix. PubMed ID: 18984468
[TBL] [Abstract][Full Text] [Related]
13. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
14. CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients.
García-Vicuña R; Gómez-Gaviro MV; Domínguez-Luis MJ; Pec MK; González-Alvaro I; Alvaro-Gracia JM; Díaz-González F
Arthritis Rheum; 2004 Dec; 50(12):3866-77. PubMed ID: 15593223
[TBL] [Abstract][Full Text] [Related]
15. Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study.
Tomanovic NR; Boricic IV; Brasanac DC; Stojsic ZM; Delic DS; Brmbolic BJ
J Gastrointestin Liver Dis; 2009 Jun; 18(2):163-7. PubMed ID: 19565045
[TBL] [Abstract][Full Text] [Related]
16. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo.
Stanford MM; Issekutz TB
J Leukoc Biol; 2003 Nov; 74(5):791-9. PubMed ID: 12960247
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.
Friedman SL
Nat Clin Pract Gastroenterol Hepatol; 2004 Dec; 1(2):98-105. PubMed ID: 16265071
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of chemokine receptor antagonists for liver disease.
Sahin H; Berres ML; Wasmuth HE
Expert Rev Clin Pharmacol; 2011 Jul; 4(4):503-13. PubMed ID: 22114859
[TBL] [Abstract][Full Text] [Related]
19. Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells.
De Minicis S; Seki E; Oesterreicher C; Schnabl B; Schwabe RF; Brenner DA
Hepatology; 2008 Dec; 48(6):2016-26. PubMed ID: 19025999
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro.
Helbig KJ; Ruszkiewicz A; Lanford RE; Berzsenyi MD; Harley HA; McColl SR; Beard MR
J Virol; 2009 Jan; 83(2):836-46. PubMed ID: 18987152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
